ArticleThe British journal of general practice : the journal of the Royal College of General Practitioners2001
Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease.
Article in The British journal of general practice : the journal of the Royal College of General Practitioners, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 30 citations in OpenAlex.
- Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study.BMC cancer · 2018Article
- Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.Clinical and translational gastroenterology · 2017Article
- Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?Pharmacoepidemiology and drug safety · 2016Article
- Pain medication management of musculoskeletal conditions at first presentation in primary care: analysis of routinely collected medical record data.BMC musculoskeletal disorders · 2014Article
- Increased gap density predicts weakness of the epithelial barrier in vivo by confocal laser endomicroscopy in indomethacin-induced enteropathy.Digestive diseases and sciences · 2014Article
- Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink.Breast cancer research : BCR · 2014Article
- Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding.Gastroenterology · 2013Article
- Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease.Pragmatic and observational research · 2012Article
- Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care.BMJ (Clinical research ed.) · 2011Article
- Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?International journal of clinical practice · 2006Review
- NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.Drug safety · 2006Review
- Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need.International journal for equity in health · 2005Article
- Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity.British journal of clinical pharmacology · 2004Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Little is known about the contribution of over-the-counter (OTC) aspirin to cardiovascular prophylaxis. To investigate this, a two-phase cross-sectional study was carried out in nine general practices in North Staffordshire. In the first phase, all patients with cardiovascular disease (CVD) were identified from computer searches using morbidity registers and drug searches. The search also identfied the subgroup receiving prescribed prophylactic aspirin. In the second phase, a questionnaire was posted to all patients with CVD who were not on prescribed aspirin to establish their current use of OTC aspirin. Overall, 69% of the CVD group used aspirin, with 26% of aspirin being OTC. OTC aspirin use was more common in those aged under 65 years, men, and the more affluent. Also, there were significant differences in OTC aspirin use between the various practices. This study shows that a considerable amount of aspirin is used OTC in those with CVD. Its use is influenced by several factors that could be addressed when considering attempts to improve the overall uptake of aspirin.
Indexed as
Identifiers
11766849PMC1314169W1889629264What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.